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Abstract
This review consist of a complete recompilation of advances made in in vitro embryo pro-
duction (IVP) and cellular therapies in the domestic cat and wild felids species. Actually, the 
domestic cat is considered a valuable model for the development of assisted reproductive 
techniques and cellular regenerative therapies that might be used in the conservation of 
endangered felids. The in vitro embryo production technologies such as in vitro fertiliza-
tion (IVF), intracytoplasmic sperm injection (ICSI) and somatic cell nuclear transfer (SCNT) 
have been applied in different species of small wild felid and big felids, resulting in live 
birth in some cases. However, more studies are needed to improve the efficiency of these 
techniques and maximize their use in the reproduction and conservation of wild felids. On 
the other hand, the mesenchymal stem cells (MSCs) therapies have been increasingly used 
in the veterinary medicine. Recent studies had reported the use of MSCs in the treatment 
of some chronic diseases in the domestic cat. For these reasons, the MSCs therapies are 
projected as a promising alternative for the treatments of chronic diseases that might affect 
wild felids that live in zoos, which could be caused by their captive environment conditions.
Keywords: wild felids, domestic cat, in vitro fertilization, somatic cell nuclear transfer, 
mesenchymal stem cells
1. Introduction
Actually, the domestic cat is considered a valuable model for the development of assisted 
reproductive technologies (ARTs) and cellular regenerative therapies that might be used in the 
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conservation of endangered felids [1, 2]. At present, according to the Red List of Endangered 
Species of the IUCN, 17 species of wild felid are classified as endangered and 8 as near threat-
ened [3]. This has led to the implementation of programs based in ARTs for the genetic pres-
ervation of endangered felids in zoological institutions from the USA and countries of Latin 
America like Mexico and Brazil [4, 5]. The in vitro embryo production (IVP) systems are a 
valuable tool that allow obtaining information regarding the developmental biology and 
might help the genetic preservation of endangered felids. The in vitro fertilization (IVF) is the 
most used IVP technique in the domestic cat and it has been used to produced embryos from 
several wild felid species [2, 6, 7]. The intracytoplasmic sperm injection (ICSI) has been used 
in the domestic cat with successful live birth [8, 9]. In some wild felid species, the ICSI has 
been used as a tool to help the embryo production in the cases of low sperm motility [8, 10]. 
The somatic cell nuclear transfer (SCNT) is a complex technique with a reduced efficiency 
compared to the techniques previously described. However, the SCNT allows the generation 
of genetically identical individuals and might help to preserve animals with a high genetic 
value [11]; the first domestic cat generated by SCNT was born in 2002 [12]. Since then, several 
research groups have tried to replicate the same achievement in wild felids. In 2003, the first 
African wildcat (Felis silvestris lybica) was born by interspecific somatic cell nuclear transfer 
(iSCNT), which proved the efficacy of this technique for the conservation of endangered felids 
[13, 14]. In general, the IVP techniques in felids still have low efficiency compared to other 
species [15]. For this reason, more studies are needed to improve these problems.
Regarding cellular therapies, cellular resources that might be potentially used in cell therapy, 
have been obtained in different species. The use of methodologies for cellular reprogramming 
has allowed the production of pluripotent and multipotent cells. However, it has been pre-
ferred that those methods that do not implicate a dependence on the expression of exogenous 
genes or changes at the cellular level may affect the viability of the cell for the use in therapy.
The use of stem cell for regenerative therapy in cats has been stimulated by the possibility to 
treat severe diseases such as chronic renal failure that is the main cause of death in felines, 
asthma and chronic feline gingivostomatitis. The domestic cats also represent a good model 
for the study of the efficacy of stem cell therapies for human diseases. Furthermore, it has 
been postulated that the use of a less differentiated cell type, as the mesenchymal stem cells, 
like nucleus donor, can improve the efficiency of the SCNT technique, which could be appli-
cable in the conservation of endangered felid species.
2. In vitro embryo production systems in the domestic cat and wild  
felids
The studies related to the use of ARTs in felids have increased considerably during the last 
years [16]. In 1990s, several studies reported the live birth of different big felid as the cheetah 
(Acinonyx jubatus), Siberian tiger (Panthera tigris altaica), clouded leopard (Neofelis nebulosa) 
and the Puma (Puma concolor) by artificial insemination (AI) [17–20]. However, scares infor-
mation has been published regarding the in vitro embryo production in big felids. On the other 
hand, several studies of IVF, ICSI and SCNT have been made in different species of small wild 
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felids [16]. The in vitro embryo production systems are a valuable tool that allows the study of 
the gamete interaction, the early embryonic development and the rescue of genetic material. 
Based on gathered information, it seems that the improvement of IVP technologies in felids 
might have a significant impact to preserve the endangered big felids.
2.1. In vitro fertilization (IVF)
The first IVF report in felids was made in the domestic cat in 1970, in which cat oocytes were 
co-cultured in vitro with spermatozoa that were previously incubated in the uterus [21]. 
Subsequently, Goodrowe et al. described the first live offspring of domestic cat by IVF after 
the transfer of embryos at 2–4 cell stage [22]. Actually, the IVF is the most used technique for 
the in vitro embryo production in the domestic cat and several wild felids species [2].
2.1.1. In vitro fertilization in the domestic cat
A series of studies have been made to improve the efficiency of the IVF. However, the domes-
tic cat embryos generated by IVF have a reduced developmental capacity compared to the 
in vivo produced embryos [23]. In the domestic cat, the percentage of blastocysts produced 
from oocytes matured and fertilized in vitro is low compared to those matured and fertilized 
in vivo (10–50 vs. 50–66%, respectively) [15]. The domestic cat embryos generated in vitro 
suffer a developmental block at the morula stage, which is attributable to deficient condi-
tions in the oocyte in vitro maturation and in the in vitro embryo culture [24, 25]. However, 
some research groups have overcome this inconvenience, reporting blastocyst rates of 50–70% 
approximately after 6, 7 or 8 days of culture [2, 16, 26–28] (Table 1).
One of the biggest problem of the IVP systems in the domestic cat, is the low compe-
tence of the in vitro matured oocytes. For this reason, some research groups have decided 
to use gonadotrophins to induce the in vivo maturation of cat oocytes. Pope have used 
porcine FSH (pFSH), to induce follicular recruitment and porcine LH, (pLH) to induce 
oocyte maturation, which have allowed the successful embryo generation by IVF, ICSI 
and SCNT [16]. Likewise, Yu et al. have described the use of eCG and hCG for the in vivo 
maturation of cat oocytes and their subsequently use in parthenogenetic activation, IVF 
and SCNT [29].
Our research group evaluated the individual effect of both gonadotrophins (pFSH and eCG) 
in the morphological quality and gene expression pattern of cumulus-oocyte complexes 
(COCs). Regarding the pFSH treatment, our study demonstrated that pFSH enhanced the 
morphological quality of COCs and increased the expression of the gonadotrophin receptor 
LHCGR. Furthermore, these results were related to an improved in vitro embryo development 
with an increased blastocyst and hatching blastocyst rates compared to the control untreated 
group (30.5 vs. 13.1% and 13.2 vs. 1%, respectively) [30]. Likewise, the treatment of domestic 
cat with eCG enhanced the morphological quality and the expression pattern of the COCs. 
The eCG treatment increased the relative expression of gonadotrophin receptors (FSHR and 
LHCGR) and gonadotrophin-induced genes (EGFR, EGR1 and ESR2) in the COCs, which 
might be related to an enhanced oocyte competence [31]. Subsequently, we observed that the 
oocytes recovered from cats treated with eCG had an enhanced developmental capacity after 
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parthenogenetic activation, which was reflected in a higher blastocyst rate compared to the 
control untreated group (32.8 and 16.9%, respectively) [unpublished data]. No differences on 
oocyte competence were observed between pFSH and eCG treatments. For this motive, we 
choose the eCG treatment for the ovarian stimulation in domestic cats. The eCG has a longer 
half-life than pFSH and only a unique dose is required, which results in a more practical pro-
tocol and less stress for the animals.
Actually, our research group has used the mild ovarian stimulation with eCG for the in vitro 
embryo production in the domestic cat. The domestic cat was treated only with a unique dose 
of 200 IU of eCG and then the recovered COCs were in vitro matured. We choose this protocol 
because no additional improvement was observed in the developmental competence using 
in vivo matured oocytes after eCG and hCG treatment. After parthenogenetic activation, no 
differences were observed in the blastocyst rate between the eCG and IVM group (32.8%) and 
the eCG and hCG group (31.4%) [unpublished data].
This protocol was used in the production of embryos by IVF (Table 1). Additionally, we 
evaluated the in vivo development of the generated blastocyst. Three embryo transfers 
were made, 23 day-7 blastocysts were transferred to two domestic cat (15 and 13 blasto-
cysts, respectively). In both cats pregnancy was established, but only the cat that received 
15 blastocysts gave birth to one female kitty after 64 days of gestation. Additionally, 
8 day-8 blastocysts were transferred to one domestic cat but no pregnancy was estab-
lished (Table 1).
In general, the transfer of felid embryos has been successfully made at earlier stages, at the 1–2 
cell stage [14] and morula or early blastocyst stages [16, 32]. Kanda et al. evaluated the transfer 
of cat embryos at the morula stage, early blastocyst stage after 4–6 days of IVC and blasto-
cyst stage after 7 days of IVC. All the recipients that received embryos at the morula stage 
(4/4, 100%) and three recipients that received early blastocyst (3/5, 60%) became  pregnant. 
Oocyte source In vitro embryo production by IVF Reference
Cleavage rate 
(%)
Morula rate 
(%)
Blastocyst rate 
(%)
Pregnancy rate 
(%)
Live birth rate 
(%)
In vivo 
maturation
62.9–88.2 40–47 33.2–71.3 31–83.3 31–83.3 [2, 8, 22, 26, 
29, 34]
In vitro 
maturation
50.2–71.5 52.2–62.7 30.0–61.1 40 20 [2, 27, 28, 105]
eCG + IVM 64.9 74.2 32.9 66.6 33.3 [Unpublished 
data]
The ranges showed were derived from several results of the respective studies cited.
• Pregnancy rate was derived from the total pregnancies established/total transferred recipients, according to each 
reference.
• Live birth rate correspond to the transferred recipient that delivered healthy kittens/total transferred recipient, ac-
cording to each reference.
Table 1. In vitro and in vivo development of domestic cat embryos after IVF using oocytes from different sources.
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However, no pregnancies were established after the transfer of 7-days blastocysts (0/3) [33]. It 
has been postulated that this might be due to the zona pellucida integrity of 7-days cat blas-
tocysts, most of the blastocysts begin to hatch the zona pellucida after day 6 and this might 
affect negative in vivo development [16, 33].
2.1.2. In vitro fertilization in small wild felids
The first live birth report was made in the Indian desert cat (Felis silvestris ornata). After IVF, 
4 Indian desert cat morulae and 10 domestic cat morulae were transferred to the uterine 
horn of a domestic cat recipient, which gave birth to one live Indian desert cat [6, 34]. This 
demonstrated that the domestic cat can be successfully used as recipient for small wild felid 
embryos. The same research group reported later, the live birth of an African wildcat gener-
ated by IVF; the embryos were cryopreserved and subsequently transferred to a domestic 
cat recipient [35]. In subsequent years, the live birth from IVF-derived embryos was reported 
in the Serval cat (Leptailurus serval), Caracal (Caracal caracal), Fishing cat (Prionailurus viver-
rinus), Sand cat (Felis margarita) and Black-footed cat (Felis nigripes) [7, 32, 36, 37]. In these 
studies, the embryos were transfer at the morula stage after 5 or 6 days of IVC to domestic cat 
recipients [7] or intra-species recipients [7, 32, 36, 37]. Additionally, the interspecific IVF has 
been described in the bobcat (Lynx rufus) and in the Iberian lynx (Lynx pardinus) as a method 
to prove the fertilization capacity of cryopreserved spermatozoa from these species using 
domestic cat oocytes [38, 39] (Table 2).
2.1.3. In vitro fertilization in big felids
Actually, only a few studies have reported the embryo production by IVF in big felid. The first 
successful report of IVF was made in tiger (P. tigris). After IVF, 86 tiger embryos at the 2–4 
cell stage were transferred into the oviduct of four recipients. One pregnancy was established 
and three cubs were delivered 107 days after embryo transfer [40]. Other study demonstrates 
that the cryopreservation of tiger spermatozoa does not affect the fertilization rate and devel-
opmental competence after IVF [41]. Regarding embryo cryopreservation, vitrification is the 
most efficient method for the cryopreservation of tiger embryos generated by IVF [42]. No 
more studies of IVF in the tiger have been published.
IVF have been performed in the Puma as well; the semen samples collected from male speci-
mens and used for the IVF showed high degree of pleomorphism (82–99%). Despite that, an 
overall fertilization rate of 43.5% was obtained [43]. Subsequently, the IVF in the Cheetah was 
described; after IVF an overall fertilization rate was only 26.6%. However, the fertilization 
rate varied from 0 to 73.3% among males [44]. Previous reports have described a high propor-
tion of abnormal spermatozoa/ejaculate in the Cheetah (31–97%) [45, 46]. A decade later, it 
was described the IVF in the lion (Panthera leo), being the first report that described the early 
embryo development in this specie (Table 2 and Figure 1).
In resume, the IVF has been used more in small wild felids than in big felids, this is mainly 
due to the easier manipulation of small wild felids during the laparoscopic oocyte retrieval 
and semen collection procedure. Furthermore, in the case of some small felids species, the 
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generated embryos can be transferred to a domestic cat recipient producing live offspring. 
Additionally, the high pleomorphism incidence in the spermatozoa of some big felid species, 
reduces the efficient of IVF in those species.
2.2. Intracytoplasmic sperm injection (ICSI)
Actually, the fertilization techniques assisted by micromanipulation are used widely in the 
human fertility clinics, allowing the in vitro embryo production in the cases of low sperm 
quality or reduced motility [48]. The ICSI is the direct injection of a single spermatozoa into 
the cytoplasm of a matured oocyte, eliminating the negative effects of low sperm motility [48]. 
ICSI is projected as a possible alternative for the in vitro embryo production in wild felids, 
where a high degree of morphological abnormality and low motility in the collected sperm 
have been observed [49].
Species In vitro embryo production by IVF Reference
Fertilization rate 
(%)
Cleavage rate 
(%)
Morula rate 
(%)
Blastocyst rate 
(%)
Pregnancy rate 
(%)
Live birth 
rate (%)
Indian 
desert cat
67.0 — — — 25.0 25.0 [34]
African 
wildcat
74.0 — — — 66.6 33.3 [2, 35]
Sand cat — 76.9 — — 25.0 25.0 [37]
Serval 33.0–68.0 — — — 16.6 16.6 [36]
Caracal — 66.0 — — 33.0 33.0 [32]
Fishing cat — 60.0 — — 9.0 9.0 [32]
Black-footed 
cat
— 47–70 — — 40.0 40.0 [7]
Bobcat 46* — 27* — — — [38]
Iberian linx 11.5–20.5* 44.7–87.5* — — — — [39]
Tiger 63.4 39.0 43.5 30.4 25.0 25.0 [40]
Puma 43.5 — — — — — [43]
Cheetah 0–73.3 17.3 — — — — [44]
Lion — 53.0 50.0 30.0 — — [47]
*Interspecific embryos generated using domestic cat oocytes.
The ranges showed were derived from several results of the respective studies cited.
• Pregnancy rate was derived from the total pregnancies established/total transferred recipients, according to each 
reference.
• Live birth rate correspond to the transferred recipient that delivered healthy kittens/total transferred recipient, 
according to each reference.
Table 2. Efficiency of the embryo production by IVF in wild felids.
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2.2.1. Intracytoplasmic sperm injection in the domestic cat
The first ICSI-derived domestic cat embryos were produced using in vivo matured oocytes. 
After the transfer of 10–11 morulae at 5 day of culture into four recipients, two pregnancies 
were established and three kittens were born [8]. It was described that the embryos gener-
ated by ICSI using in vitro matured cat oocytes had a decreased developmental competence 
compared to those derived from in vivo matured oocytes [9]. Despite this, the ICSI embryos 
generated from in vitro matured cat oocytes are able to produce live births [9]. Subsequently, 
the production of cat embryos by ICSI using in vitro matured oocytes and frozen epididy-
mal spermatozoa was described. The generated embryos were capable to reach the blastocyst 
stage [50]. However, the blastocyst rate was low (6.6%) compared to the previously reported 
by Pope et al. (42.9%) and Gómez et al. (19%) [8, 9, 50].
2.2.2. Intracytoplasmic sperm injection in small wild felids and big felids
No many studies related to the ICSI in wild felids have been published. The first report was 
made in the jaguarundi (Herpailurus yagouaroundi). Nine jaguarundi embryos that reached the 
early morula stage at day 5 of culture were transferred into two domestic cat recipients, but 
none of them developed to term [8]. Subsequently, it was described the generation of Fishing 
cat embryos by ICSI, 19 day-2 cleaved embryos were transferred into the oviduct of one fish-
ing cat but no pregnancy was established [32] (Table 3).
It has been described that the generation of lion embryos by ICSI using sperm collected by 
percutaneous epididymal sperm aspiration (PESA) from two vasectomized male lions. After 
ICSI, all the cleaved embryos reached the morula stage at day 5 of culture [51]. Subsequently, 
Figure 1. Progresses in the embryo generation by IVF, ICSI and SCNT in the domestic cat and wild felids.
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it was described that the lion oocytes are able to mature in vitro and after ICSI the embryos 
are able to reached blastocyst stage. However, the embryos reached the morula stage at day 
6 and the blastocyst stage at day 9, which indicated a slow in vitro development [52]. More 
recently, the interspecific ICSI in the leopard (Panthera pardus) and Cheetah using domestic 
cat oocytes was described. The interspecific embryos were able to develop in vitro until the 
blastocyst stage with a similar rate compared to domestic cat embryos. This demonstrates that 
the developmental capacity of big felid spermatozoa can be evaluated by interspecific ICSI 
[10] (Table 3 and Figure 1).
More research is needed to evaluate the ICSI in big felids. The ICSI allows the in vitro embryo 
generation in the cases of poor sperm quality, which is consisted in some big felid species. 
Furthermore, the interspecific ICSI using domestic cat oocyte offers the possibility to study 
the in vitro developmental capacity in these species.
2.3. Somatic cell nuclear transfer (SCNT)
During the SCNT, the oocyte cytoplasmic factors are capable to reprogram the expression pat-
tern of a somatic cell into a pluripotent embryonic state, allowing it to initiate the early devel-
opment [53]. The fact that a differentiated cell must be reprogramed to a pluripotent stage 
made the SCNT a complex technique with a reduced efficiency. Different factors may affect 
the efficiency of the SCNT, some of these are: the quality of the donor nucleus or the recipient 
oocyte and the synchronization between the donor nucleus and the oocyte. These factors can 
lead to an inadequate reprogramming of the donor genome and to a reduced embryo devel-
opment [11]. Despite this low efficiency, the SCNT is the only technique that may generate 
genetically identical individuals, which bring the possibility to rescue the genetic material of 
endangered species.
Species In vitro embryo production by ICSI Reference
Cleavage rate (%) Morula rate (%) Blastocyst rate (%) Pregnancy rate (%) Live birth rate (%)
Domestic 
cat
57.0–81.6 50.8–81.0 6.6–42.9 33.3–50.0 22.2–50.0 [8, 9, 50]
Fishing cat 22.0–70 — — 0 — [32]
Jaguarundi 55.6 50.0 — 0 — [8]
Cheetah 66.3–73.6* — 21.0–32.6* — — [10]
Lion 30.8–60.0 28.6–100 28.6–50 — — [51, 52]
Leopard 35.3–73.7* — 9.8–21.0* — — [10]
*Interspecific embryos generated using domestic cat oocytes.
The ranges showed were derived from several results of the respective studies cited.
• Pregnancy rate was derived from the total pregnancies established/ total transferred recipients, according to each 
reference.
• Live birth rate correspond to the transferred recipient that delivered healthy kittens/total transferred recipient, 
according to each reference.
Table 3. Efficiency of the in vitro embryo production by ICSI in domestic and wild felids.
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2.3.1. Somatic cell nuclear transfer in the domestic cat
The first domestic cat produced by SCNT was made using cumulus cells as nucleus donors for 
metaphase II enucleated oocytes. A live kitten was born 66 days after the embryo transfer [12]. 
Subsequently, it was described the use of cat fetal fibroblasts and adult fibroblasts as nucleus 
donors for SCNT. No statistical differences were observed in the fusion, cleavage and blas-
tocyst rates when fetal or adult fibroblasts were used. Furthermore, live birth was obtained 
using both type of cells [54].
In addition, the advances of the SCNT in felids have led the production of transgenic animals. 
A domestic cat that expresses the red fluorescent protein was generated using a retroviral 
vector for the incorporation of the transgene in the somatic cells used as nucleus donor [55]. 
A year later, it was reported the birth of a transgenic cat that express the green fluorescent 
protein, which was generated using a lentiviral vector to modify the donor cells [56]. The 
objective of these studies was to potentiate the use of the domestic cat as a biomedical model 
for the study of analogues diseases in humans. This proves that these techniques  could be 
implemented to generate genetically identical animals that have integrated coding genes for 
specific human diseases.
2.3.2. Somatic cell nuclear transfer in small wild felids
The scares availability of gametes is one of the biggest problem for the in vitro embryo pro-
duction in endangered animals due to their reduced population. The interspecific somatic cell 
nuclear transfer (iSCNT) is proposed as alternative for this problem. It has been demonstrated 
that the domestic cat oocyte can be used as recipient cytoplast for somatic cells of wild felids, 
generating embryos of these species [13]. It was reported the live birth of African wildcats 
by iSCNT using the domestic cat oocyte as recipient cytoplast and a female domestic cat as 
recipient for the cloned embryos [14]. Subsequently, the same research group described the 
live birth of three Sand cats by iSCNT [57]. Different studies have tried to replicate those 
results in other felid species, but no live births have been reported. This may be because the 
African wildcat and the Sand cat are subspecies closely related to the domestic cat, which 
might improve the efficiency of cell reprograming during iSCNT. However, it seems when 
somatic cells from felid species, phylogenetically more distant from the domestic cat are used, 
the efficiency of the iSCNT tend to decrease.
In the leopard cat (Prionailurus bengalensis), the embryo generation by iSCNT was reported, 
using domestic cat oocytes as cytoplasm recipients. The cloned embryos reached the blas-
tocyst stage. However, after embryo transfer, pregnancy was established but no live births 
were obtained [58]. Subsequently, the generation of embryos of rusty-spotted cat (Prionailurus 
rubiginosus) and black-footed cat by iSCNT was described. The cloned embryos were capable 
to develop until the blastocyst stage. After embryo transfer, the rusty-spotted cat embryos 
were not able to implant. Meanwhile, the transferred black-footed cat embryos were able to 
establish pregnancy but all the fetuses were reabsorbed later [59]. Similarly, in the marbled 
cat (Pardofelis marmorata) and flat-headed cat (Prionailurus planiceps); after iSCNT, the embryos 
were able to develop in vitro until the blastocyst stage. However, no pregnancies were estab-
lished after embryo transfer into domestic cat recipients [60].
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2.3.3. Somatic cell nuclear transfer in big felids
There are scarce reports regarding to the iSCNT in big felids. The first report was made in the 
tiger, in which pig oocytes were used as recipient cytoplast. However, a blastocyst rate of only 
0.7% was obtained [61]. More recently, leopard, tiger and lion cloned embryos were generated 
by iSCNT, using rabbit oocytes as cytoplast recipients. This study described that the rabbit 
oocytes were capable to reprogram big felid somatic cells. However, the blastocyst rate after 
in vitro culture was 5–6% in the three species [62].
On the other hand, several methods have been implemented to improve the low efficiency 
of the SCNT such as embryo aggregation. This consists of the in vitro culture of two or more 
zona-free embryos together in the well of the well system (WOW) [63]. It was reported that 
the aggregation of cloned cheetah embryos and cloned tiger embryos generated by iSCNT 
improves the in vitro development in these species. However, the developmental capacity of 
cheetah and tiger cloned embryos was reduced compared to domestic cat cloned embryos 
[63, 64] (Table 4 and Figure 1).
In resume, the iSCNT have a reduced efficiency and it seems that these problems are more 
evident when the species used as nucleus donor are more distant phylogenetically from 
the domestic cat. This might be related to an incomplete donor nucleus reprogramming. 
Regarding the big felids, it has been proved that pig and rabbit oocytes are able to reprogram 
big felid donor cells, but they are not as efficient as domestic cat oocytes. The embryo aggre-
gation has been postulated as a method that improves the developmental capacity of big cat 
cloned embryos. However, the developmental capacity of these embryos is reduced com-
pared to domestic cat cloned embryos. More studies are needed to improve the reprograming 
events that allow the development of iSCNT-derived embryos in big felids.
2.4. Gene expression analysis as indicator of developmental capacity in felid embryos
During the early development, the expression of specific genes allows the embryo progress 
from one stage to the next [65]. For this reason, the relative quantification of mRNA from cru-
cial genes during the early development is considered an adequate indicator of the embryo 
quality [66]. The pluripotency markers OCT4, SOX2 and NANOG and the differentiation 
markers CDX2 and GATA6 play a crucial role during the embryo development in the domes-
tic cat [67]. According to this, an aberrant expression pattern of these genes might be related 
to a reduced developmental competence of the produced embryos [67].
It has been described that the gonadotrophin treatments in the domestic cat improve the gene 
expression pattern in the COCs and in the produced embryos. The ovarian stimulation of 
domestic cat with pFSH enhances the embryo developmental capacity and increases expres-
sion of OCT4 and GATA6 at the blastocyst stage [30].
Furthermore, in the domestic cat, it has been described that the in vitro-produced blastocysts 
had a decreased relative expression of OCT4 compared to the in vivo-produced blastocysts 
[67]. This demonstrated that the in vitro culture affect negatively the gene expression pat-
tern of domestic cat embryos, which is reflected in their reduced developmental competence. 
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The technique used for the embryo generation might also affect the gene expression pattern. 
A decreased OCT4 expression was related to a reduced developmental capacity of feline 
embryos generated by iSCNT [68]. Moreover, it has been described that cheetah embryos 
generated by iSCNT have an aberrant expression of OCT4, SOX2, NANOG and CDX2 com-
pared to domestic cat embryos generated by SCNT and IVF. This was in accordance with a 
reduced developmental competence of the cheetah cloned embryos, which might be due to an 
inadequate reprogramming of the cheetah donor cell by the cat oocyte [63].
3. Cellular regenerative therapies in felids
The challenge in feline cell therapy is to offer treatment options to different diseases and to 
use stem cells in endangered animals is another challenge. This latter challenge is even more 
Species In vitro embryo production by SCNT Reference
Clevage rate 
(%)
Morula rate 
(%)
Blastocyst rate 
(%)
Prenancy rate 
(%)
Live birth rate 
(%)
Domestic cat 57.6–98.2 4.0–49.5 2.0–47.7 20.0 20.0 [13, 14, 54, 
63]
African 
wildcat
79.0–89.0 35.0–51.0 17.0–33.0 40.0–50.0 25.0 [13, 14]
Sand cat 83.0–97.0 — 6.0–43.0 30.0–32.0 12.0–25.0 [57]
Black-footed 
cat
85.2 — 2.6 45.0 0 [59]
Leopard cat 67.4 — 7.3 57.1 0 [58]
Rusty-spotted 
cat
85.5 — 26.2 0 — [59]
Marbled cat 93.3 23.3 5 — — [60]
Flat-headed cat 96.7 53.3 8.3 0 — [60]
Tiger 93.7–95.9 18.6–25.4 3.4–12.7 — — [64]
Cheetah 87.2–96.7 37.4–38.2 16.7–28.6 — — [63]
Lion 68.4–78.7 12.1–29.8 3.4–6.5 [62]
Leopard 63.2–72.9 11.3–16.6 3.4–5.2 — — [62]
The ranges showed were derived from several results of the respective studies cited.
• Pregnancy rate was derived from the total pregnancies established/total transferred recipients, according to each 
reference.
• Live birth rate correspond to the transferred recipient that delivered healthy kittens/total transferred recipient, 
according to each reference.
Table 4. Efficiency of SCNT in the domestic cat and wild felid species.
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complicated because of the low availability of tissue to isolate stem cells in these species. 
However, biotechnology can bring us closer to the possibility of improving techniques for 
obtaining stem cells for therapy and tissue regeneration that may also contribute to the conser-
vation of these individuals. This review tries to cover the main aspects of stem cells in domes-
tic cats and its future application in wild cats, as well as their obtaining and characterization.
3.1. Induced pluripotent feline stem cells
The induced pluripotent stem cells (iPSCs) are generated by the induced expression of plu-
ripotency transcription factors in cells that normally do not express. In this way, stem cells 
from somatic and differentiated cells can be obtained. Takahashi and Yamaka were the first to 
develop and implement this technique in 2006, who induced somatic cells mouse in iPSC by 
transfection of the cells with the transcription factors “OSKM” corresponding to transcription 
factor binding octamer 3/4 (Oct3/4), high protein group mobility-related gene Sry2 (Sox2), 
Kruppel factor 4 (Klf4) and c-Myc oncoprotein [69].
To date, there are reports of iPSC generated from endangered feline species such as snow 
leopard, tiger, jaguar and African serval [70, 71]. Protocols for induction to pluripotency 
in wild cats conclude that Nanog is a key factor in reprogramming [68]. For this reason, 
reprogramming cocktails included the four Yamanaka factors plus Nanog and use culture 
medium supplemented with LIF and SFB. When Nanog was removed from the cocktail, 
the reprogramming efficiency was greatly reduced and the colonies reached only up to 
the seventh pass (P7) [70]. On the other hand, the inclusion of Nanog made that the iPSCs 
colonies could be expanded in vitro, were positive for alkaline phosphatase and for OCT-4, 
NANOG and SSEA-2 proteins at the passage 14 (P14) [70]. Oct4 and Nanog endogenous 
were detected by RT-PCR at passage 4 and 14, indicating reprogramming and reactiva-
tion of endogenous pluripotency genes and the transgenes of Oct4, Sox2 and Nanog were 
silenced at the passage 14 [70]. These cells showed a good set of stem cell characteristics 
like teratoma formation and genetic markers for the differentiation to ectoderm, endoderm 
and mesoderm. A curious fact of these protocols is the use of mouse embryonic fibroblasts 
(MEF) as feeder and the absence of FGF2 in the culture medium. In general, regarding 
the culture medium, this is simpler than the used in other species and in the domestic 
cat embryonic stem cell (ESC) culture [72]. This could be considered advantageous to the 
use of the resources, but may affect the obtaining of a “naïve” phenotype in these feline 
iPSCs. However, there remains doubt about the pluripotency of these cells because the 
chimera formation could not be assessed. There is a great interest for the feline iPSCs for-
mation because they represent a novel opportunity for the preservation of species through 
assisted reproduction. The reason why there are no publications of IPSCs in domestic cats 
is unknown. According to some researchers, there is not enough funding for research in cell 
therapy in cats or it is not probably an area in demand [73]. However, the results obtained 
in the published studies gave the impression that the techniques in this species are still 
complex and require a high level of standardization.
Despite all these difficulties, the therapeutic and conservation potential that can be reached 
with cellular reprogramming in domestic and wild felids is promising.
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3.2. Mesenchymal stem cells (MSC)
Mesenchymal stem cells (MSC), also called by some authors, as mesenchymal stromal cells 
are unspecialized cells that have the ability to self-renew by cell division and differenti-
ate into specialized cells [74]. The MSCs are involved in the tissue regeneration by two 
different mechanisms. They may contribute directly to tissue repairing by differentiation 
into specific cell phenotypes such as, ligaments, tendons or alternatively fibroblasts, but 
not necessarily exclusive. These adult stem cells have the ability to produce extracellu-
lar matrix and bioactive proteins such as growth factors, anti-apoptotic and chemotac-
tic agents that have an important effect on the dynamic cellular, production of anabolic 
effects, stimulate neovascularization and additional recruitment of stem cells the site of 
injury. Stem cells recruited at these sites can differentiate and/or produce biologically 
active peptides [75]. MSCs have a fibroblast-like morphology, must be adherent to plastic, 
express surface molecules like CD105, CD73 and CD90 and have a negative expression 
of CD45, CD34, CD14 o CD11b, CD79α o CD19 and HLA-RD. In addition, the MSCs are 
capable to differentiate in vitro into osteoblasts, adipocytes and chondroblasts [74, 76]. 
However, characterization of MSCs in veterinary species is more difficult due to the lack of 
specificity or low affinity antibodies, which are generally made against human or murine 
antigens. These differences in the surface markers may be due to specific features of the 
tissue from which the MSCs were collected. In the domestic cat, some authors report dif-
ferences in the expression of surface markers in the MSCs depending of the tissue from 
which they were isolated (Table 5 and Figure 2). An additional characteristic reported 
in cat MSCs derived from adipose tissue is the expression of pluripotency markers as 
NANOG, KLF4 and OCT4 [77].
3.2.1. Tissues source of mesenchymal stem cells (MSCs) in cats
In animals and humans, different tissues represent a potential resource for obtaining MSCs. 
The bone marrow was the first tissue explored; one of the best sources of production and so 
far the most widely used in cell therapy. However, other sources such as adipose tissue, have 
been investigated and successfully used. In the field of veterinary medicine, depending on the 
target species, the tissue from which these cells are obtained is crucial and can be influenced 
by the weight, size and the handling of the patient. However, the method for obtaining these 
tissues does not always correlate with a good source of MSCs. Therefore, the investigation 
of other resources for obtaining MSCs in different species is important, considering that the 
results between species cannot be extrapolated in all cases.
3.2.1.1. Bone marrow
MSCs isolated from bone marrow (BM-MSCs) has been described in many animal species such 
as mice, rabbits, horses, pigs, cattle, dogs and cat [78–83]. Maciel and colleagues conducted 
a study of the morphology of BM-MSC in felines and they noted the predominance of two 
types of cells, spindled and elongated [84]. It has been reported that feline BM-MSCs have the 
potential to differentiate toward neuronal lineage [85]. Feline BM-MSC after the fourth pas-
sage becomes more homogeneous and express surface markers like CD44, CD105 and CD29.
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Figure 2. Representative graphic of the surface markers expression in the domestic cat mesenchymal stem cells.
Adipose tissue Bone marrow Blood Amniotic membranes Reference
POS CD90 CD90 CD90 CD90 [77, 86–90]
CD44 CD44 CD44 CD44 [86–90]
CD105 CD105 CD105 [77, 86–90]
CD146 [77]
CD73 [90]
NEG CD4 CD4 CD4 [86, 90]
CD14 CD14 [77, 87, 88]
CD18 [89]
CD34 CD34 [87, 88]
CD45 CD45 [77, 87, 88]
CD73 CD73 [77, 87]
CD271 [77]
MHC II MHC II MHC II [77, 86, 87, 92]
Table 5. Expression markers of domestic cat mesenchymal stem cells derived from different tissues.
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3.2.1.2. Peripheral blood
Peripheral blood is another tissue of which has been documented obtaining of MSCs. 
Compared to bone marrow, it is a safer and less painful resource with less subsequent compli-
cations. Feline peripheral blood (fPBMSCs) has been isolated from venous blood of cats and 
expanded in culture [90]. The morphology and capacity for differentiation into mesoderm 
lineages of these MSCs is similar to others obtained from different feline tissues. However, 
these MSCs require a special culture medium containing 5% autologous plasma (AP) and 10% 
fetal bovine serum (FBS), showing a similar growth curve that others reports because its pro-
liferation is limited to the seventh passage [90]. These cells express CD44 and CD90 surface 
markers and are negative to major histocompatibility class II and CD4.
3.2.1.3. Fetal membranes
The interest of MSCs derived from fetal and extra-embryonic tissues has increased because 
of its usefulness in the field of regenerative medicine [75, 92–94]. In felines, these MSCs are 
obtained from tissues discarded after birth or from procedures such as cesarean operation and 
ovariohysterectomy. These cells have been isolated and successfully expanded. It was reported 
that these cells have an adequate level of homogeneity at the passage 3, as it was found in 
canines [95]. Unlike other tissues, the cell population of the feline AMSC increases consider-
ably after the passage 7, with higher values than those reported in horses and dogs, the cell 
number tends to increase along with number passages [95]. Additionally, the viability of these 
cells after cryopreservation was similar to the viability of fresh cells, which is ideal for cell 
banks and future applications in cell therapy [95]. AMSCs feline express CD73 and CD90 sur-
face markers but did not express hematopoietic specific markers CD34, CD45 and CD79 [95].
3.2.1.4. Adipose tissue
Adipose tissue is abundant and more accessible than other tissues and is the most commonly 
used in cellular veterinary therapies [89]. Cellular therapies for animals using cells derived 
from adipose tissue (AMSC) have been used to treat osteoarthritis, injuries of ligaments and 
tendons in canine and equine, feline gingivostomatitis with good results and other patholo-
gies that are being studied as chronic renal failure, asthma and chronic enteropathy in domes-
tic cats [91, 96–98]. Feline AMSCs have been isolated and characterized from black-footed cat, 
an endangered feline [77]. Both cat and black-footed cat AMSCs showed potential adipogenic, 
osteogenic and chondrogenic differentiation, but the surface marker expression of black-
footed cat AMSCs is unknown and it could be difficult to evaluate because of the specificity of 
the antibodies. However, these results obtained from endangered felines can be used in ARTs 
for their conservation such as SCNT, or potentially be used in cell therapy of individuals of 
the same species.
3.2.1.5. Potential sources of MSCs
Brain, muscle, synovial fluid, tendon, placenta and dental pulp are others potential sources 
for obtaining MSCs in several species [99–101]. Some of these tissues could eventually be 
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used to isolate mesenchymal stem cells in felines to perform extensive characterization pro-
cedures, which could defined if these cells have any potential to be employed in cell therapy. 
Considering that stem cells can be isolated for other purposes such as species conservation, 
spermatogonial stem cells (SSCs) can be isolated from testicular tissue. In domestic cats, these 
cells were successfully isolated and cultured in vitro, but its viability was compromised and 
the culture only reached 57 days [102]. Interestingly, SSCs can differentiate into sperm and be 
available for transplantation in testicular tissue. The first successful xenotransplant study was 
performed using ocelot SSCs in domestic cat testicular tissue [103]. Ocelot (Leopardus pardalis) 
spermatozoa were observed in the cat epididymis 13 weeks following transplantation sug-
gesting that the domestic cat may be a useful species to produce gametes from another close 
species. This study along with others demonstrates the importance of the domestic cat as a 
research model for the conservation of endangered species [103].
3.3. Doses and routes of administration for MSC treatment in domestic cats
To date, mesenchymal stem cells are the only ones that have been evaluated in treatments 
of certain pathologies in domestic cats. The establishment of the treatment doses of MSCs in 
cats has been a main point to obtain the expected therapeutic effect and to reduce the adverse 
effects that may occur. After the adequate characterization of MSCs depending on their place 
of origin, the challenge is to evaluate the dose response and the route of administration. It 
has been reported that the intravenous route is the most chosen in the treatments with MSCs. 
Allogenic and autologus administration of MSCs in cats have not shown any side effects [96, 
98, 104]. More studies are still required to determine alternative administration routes that 
may increase the treatment efficacy. Furthermore, the doses used are still a topic of discus-
sion, but some doses are proposed for certain treatments (Table 6). The effects of reported 
treatments suggest that they can be seen since the third dose of MSCs administration [96].
4. Conclusions
Great advances have been made in the in vitro embryo production and cellular therapies in 
felids. The studies first made in the domestic cat have allowed the subsequent application 
of these techniques in endangered felids. Regarding the in vitro embryo production, several 
Specie Doses Administration Pathology Age Treatment Reference
domestic cat 3 doses of 2 × 106 cells/kg Intravenous Chronic renal 
failure
10–15 years Allogenic [98]
Domestic 
cat
2 doses of 2 × 106 cells/kg Intravenous Enteropathy 7–15 years Allogenic [104]
Domestic 
cat
1 doses of 5 × 106 cells/kg Intravenous Gingivostomatitis 1–14 years Autologus [91]
Table 6. Treatment by pathology, doses and administration route of MSCs in felines.
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live birth reports have demonstrated the efficiency of these technique in the conservation of 
endangered felids. However, more studies are needed to improve their efficiency especially 
in the case of the SCNT. On the other hand, the results in cell therapy applied to felids set 
the background for future research. There is still need to identify the potential of stem cells 
isolated from different felid tissues. Additionally, the tools for the isolation and characteriza-
tion of these cells in wild felid species must be improved considering that it is a very limited 
resource. However, there are unexplored alternatives for the use of stem cells, not only as 
therapy for different pathologies but also for obtaining gametes or other cell types from which 
is possible to rescue genetic material.
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